Evidence map›Paper›PMID 35784665›Full record

ArticleSAGE open medicine2022

Study of streptococcal antibody (anti-streptolysin O) among healthy children in Bangladesh.

Santosh Kumar Saha, Kamrun Nahar Choudhury, Salma Zareen, Sabrina Mousum, Mohammad Abdullah Al Mamun, M Atiqul Haque

Open access · goldAbstract read
In one paragraph

Article in SAGE open medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Streptococcal Serology Reference Intervals in an Australian Pediatric Cohort.Journal of the Pediatric Infectious Diseases Society · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Santosh Kumar SahaNational Institute of Cardiovascular Diseases and Hospital, Dhaka, Bangladesh.ORCID https://orcid.org/0000-0002-5402-3414
Kamrun Nahar ChoudhuryNational Center for Control of Rheumatic Fever and Heart Disease, Dhaka, Bangladesh.
Salma ZareenNational Center for Control of Rheumatic Fever and Heart Disease, Dhaka, Bangladesh.
Sabrina MousumBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
Mohammad Abdullah Al MamunNational Heart Foundation Hospital and Research Institute, Dhaka, Bangladesh.
M Atiqul HaqueBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
National Institute of Cardiovascular Diseases · BDBangladesh Medical University · BDNational Heart Foundation Hospital & Research Institute · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: The standard reference value of anti-streptolysin O (ASO) titre for diagnosing acute rheumatic fever (RF) in children is yet to be determined in Bangladesh. We aimed to measure the upper limit of the normal (ULN) of ASO titre among healthy children to determine the cut-off value for the diagnosis of RF in Bangladesh. Methods: A total of 400 healthy children aged 5-15 years with no history of fever, sore throat and impetigo during the last 8 weeks of the study were enrolled. The respondents were randomly selected from an urban non-slum area, an urban slum area and a rural area of Bangladesh. ASO titre was measured using a turbidimetric immunoassay based on the principle of an agglutination reaction. The 80th percentile value was considered as the ULN of ASO titre. Results: Approximately 55% of the children were male. The mean (SD) age of children was 9.1 (2.7) years. The ULN of ASO titre for 5-15 years aged children was 217.4 IU/mL. Conclusion: Our reference value of ASO titre at the 80th percentile will be an essential guide for clinicians to diagnose acute RF.

Indexed as

Anti-streptolysin OBangladeshchildrenrheumatic feverupper limit of normal

Identifiers

PMID35784665
PMCPMC9244936
OpenAlexW4285114312

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.